期刊文献+

Effect of angiotensin Ⅱ receptor blocker on glucose-induced mRNA expressions of matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 in rat mesangial cells 被引量:11

Effect of angiotensin Ⅱ receptor blocker on glucose-induced mRNA expressions of matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 in rat mesangial cells
原文传递
导出
摘要 细胞外的矩阵蛋白质的减少的降级玩的背景在糖尿病的 nephropathy 的发作的一个重要角色。矩阵 metalloproteinase-9 (MMP-9 ) 是矩阵 metalloproteinase 家庭的成员,和 metalloproteinase-1 (TIMP-1 ) 的织物禁止者与这个过程被联系。血管收缩素 il (AII ) 也在糖尿病的 nephropathy 的发展起一个重要作用。试图在老鼠 mesangial cells.Methods 老鼠 mesangial 房间在 MMP-9 和 TIMP-1 的导致葡萄糖的 mRNA 表情上调查血管收缩素受体 blocker 的效果的这研究进 5 个组有教养、划分:正常葡萄糖(组 NG ) ,高葡萄糖(组 HG ) ,组 NG+AII, NG+AIl+saralasin (组 NG+AII+S, saralasin 是所有受体 blocker ) 并且 HG+saralasin (组 HG+S ) 。在房间被孵化 24 个小时以后,在上层清液的所有集中被放射性免疫测定和 MMP-9 的表示测量, TIMP-1 mRNA 是由反向的抄写聚合酶链反应(RT-PCR ) 的 assayed 所有集中是的 .Results 在组 HG 更高((56.90 慮敳吗?? Background The decreased degradation of extra-cellular matrix proteins plays an important role in the onset of diabetic nephropathy. Matrix metalloproteinase-9 (MMP-9) and tissue inhibitor of metalloproteinase-1 (TIMP-1), which are members of the matrix metalloproteinase family, are associated with this process. Angiotensin Ⅱ (AⅡ) plays an important role in the development of diabetic nephropathy also. This research aimed to investigate the effect of angiotensin Ⅱ receptor blocker on glucose-induced mRNA expressions of MMP-9 and TIMP-1 in rat mesangial cells. Methods Rat mesangial cells were cultured and divided into 5 groups: normal glucose (group NG), high glucose (group HG), group NG+AⅡ, NG+AⅡ+saralasin (group NG+AⅡ+S, saralasin is the AⅡ receptor blocker) and HG+saralasin (group HG+S). After the cells were incubated for 24 hours, AⅡ concentrations in the supernatant were measured by radioimmunoassay and the expression of MMP-9 and TIMP-1 mRNA was assayed by reverse transcription-polymerase chain reaction (RT-PCR). Results AⅡ concentrations were higher in group HG ((56.90±13.54) pg/ml) and group HG+S ((51.30±5.96) pg/ml) than in group NG ((37.89±8.62) pg/ml, P〈0.05), whereas there was no significant difference between group HG and group HG+S. The expression of MMP-9 mRNA and MMP-9/TIMP-1 mRNA ratio in group NG+AⅡ (MMP-9, 0.33±0.04; MMP-9/TIMP-1, 0.40±0.06) and group HG (MMP-9, 0.36±0.02; MMP-9/TIMP-1, 0.45±0.03) were decreased more significantly than those in group NG (MMP-9, 0.72±0.02; MMP-9/TIMP-1, 1.21±0.07). These values in group NG+AⅡ+S (MMP-9, 0.71±0.02; MMP-9/TIMP-1, 1.18±0.05) were higher than those in group NG+AⅡ, and the values in group HG+S (MMP-9, 0.71+0.02; MMP-9/TIMP-1, 1.16±0.05) were higher than those in group HG (all were P〈0.05). TIMP-1 mRNA expression was increased more significantly in group NG+AⅡ (0.81±0.03) and group HG (0.80±0.03) than in group NG (0.59±0.02), but it was lower in group NG+AⅡ+S (0.60±0.01) than in group NG+AⅡ and also lower in group HG+S (0.61±0.01) than in group HG (all were P〈0.05). Conclusions High glucose stimulates AⅡ production. Both high glucose and AⅡ induce a decrease in MMP-9 mRNA expression and MMP-9/TIMP-1 mRNA ratio as well as an increase in TIMP-1 mRNA expression, which can be reversed by saralasin, suggesting that high glucose can aggravate impaired matrix degradation by altering gene expression of MMP-9 and TIMP-1 and that the effect of high glucose may be mediated by AⅡ.
出处 《Chinese Medical Journal》 SCIE CAS CSCD 2007年第21期1886-1889,共4页 中华医学杂志(英文版)
关键词 葡萄糖 血管收缩素 缓蚀剂 动物模型 细胞 matrix metalloproteinase-9 tissue inhibitor of metalloproteinase-1, high glucose angiotensin Ⅱ
  • 相关文献

参考文献2

二级参考文献16

  • 1Dr. M.-L. Gross,A. El-Shakmak,A. Szábó,A. Koch,A. Kuhlmann,K. Münter,E. Ritz,K. Amann.ACE-inhibitors but not endothelin receptor blockers prevent podocyte loss in early diabetic nephropathy[J].Diabetologia.2003(6)
  • 2F. Bonnet,M. E. Cooper,H. Kawachi,T. J. Allen,G Boner,Z. Cao.Irbesartan normalises the deficiency in glomerular nephrin expression in a model of diabetes and hypertension[J].Diabetologia.2001(7)
  • 3Doublier S,Salvidio G,Lupia E,Ruotsalainen V,Verzola D,Deferrari G,Camussi G.Nephrin expression is reduced in human diabetic nephropathy: Evidence for a distinct role for glycated albumin and angiotensin II[].Diabetes.2003
  • 4Aaltonen,P,Luimula,P,Astrom,E.Changes in the expression of nephrin gene and protein in experimental diabetic nephropathy[].Laboratory Investigation.2001
  • 5Wu YG,Lin H,Qi XM,Wu GZ,Qian H,Zhao M,Shen JJ,Lin ST.Prevention of early renal injury by mycophenolate mofetil and its mechanism in experimental diabetes[].International Journal of Immunopharmacology.2006
  • 6Lewis,E.J.,Hunsicker,L.G.,Clarke,W.R.,Berl,T.,Pohl,M.A.,Lewis,J.B.Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes[].The New England Journal of Medicine.2001
  • 7Anderson S,Rennke HG.Brenner BM: Nifedipine versus fosinopril in uninephrectomized diabetic rats[].Kidney International.1992
  • 8Fujihara,CK,Malheiros,DM,Zatz,R,Noronha,ID.Mycophenolate mofetil attenuates renal injury in the rat remnant kidney[].Kidney International.1998
  • 9Soulis,T,Cooper,ME,Vranes,D,Bucala,R,Jerums,G.Effects of aminoguanidine in preventing experimental diabetic nephropathy are related to the duration of treatment[].Kidney International.1996
  • 10Fossati P,Prencipe L,Berti G.Enzymic creatinine assay: a new colorimetric method based on hydrogen peroxide measurement[].Clinical Chemistry.1983

共引文献38

同被引文献53

引证文献11

二级引证文献34

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部